Searched for
FDC BAN IN INDIA
ORS sales melt in March after govt's stricter labelling normsIndia’s oral rehydration solution (ORS) market has declined after regulatory action restricted the labelling of sugary drinks as ORS, affec...- 'Irrational' fixed dose combos harmful, may face ban: Expert panelSeveral personal care products containing ingredients like aloe vera, jojoba oil, and orange oil are likely to be banned in India. An exper...
- Lens on fixed-dose combination drugs containing vitamins, mineralsA committee had been set up under the chairmanship of CK Kokate, former vice-chancellor of KLE University, Belgaum, to review the safety, e...
- India bans 14 fixed-dose medicines for likely posing risks to healthThe Indian government has banned 14 types of fixed-dose combination (FDC) medicines due to a lack of therapeutic justification and potentia...
- SC exempts painkiller Saridon from the banned list in IndiaThe health ministry had banned the manufacture, sale and distribution of 328 fixed dose combinations (FDCs) of drugs in September last year.
- Government prohibits 328 fixed dose combinationsThe ban is effective immediately and may shave off over Rs 1,500 crore from India’s Rs 1.18 lakh crore pharmaceutical industry
- Panel recommends ban on 343 fixed dose combination medicinesThis report will be sent to the health ministry in the next two weeks, following which the government will decide the fate of these drugs, ...
- SC for relook into 349 FDC medicines by drug advisory boardThe FDC were banned by the Centre on the grounds that they involved "risk" to humans and safer alternatives were available.
- SC refers 349 FDC medicines to Drug Advisory Board for relookA bench said that the 349 FDCs were banned pursuant to the Kokate Committee report, by notifications of the central government under Sectio...
- Year-end special: Five bans of 2016Bans test the limits of our regulatory frameworks. 2016 had its fair share of bans. Here are the top five.
- Delhi High Court quashes government ban on over 300 medicines like Corex, SaridonThe brands included D'Cold Total, Corex cough syrup, and Vicks Action 500, among others.
- Buy Cadila Healthcare Ltd., target Rs 440.0 : CitigroupCitigroup sees limited scope for further deterioration in Cadilla Healthcare financials.
- Neutral Dr. Reddy's Laboratories, target Rs 3070: Credit SuisseGiven low utilisation, incremental capex should be low, cautions the global investment bank. The near-term capex should stay high at $200mn...
- Pharma sector grows 7.7 per cent in May; FDC ban weighsUnder the non-NLEM category, growth in May for domestic players and MNCs almost doubled to 9 per cent and 7.1 pc as against April's 4.6 pc ...
- HC reserves verdict on pleas against ban on 344 FDCsThe court had on March 14 stayed the Centre's ban on 344 FDC drugs and this interim order was passed in each and every case filed before it...
- India used as a dumping ground for banned drugs: Government counselThe Centre is not influenced by actions previously taken by the Drug Controller General of India (DCGI), who had granted the approvals to t...
- India an FDC dumping ground: Additional Solicitor General Sanjay JainPharmaceutical companies have long used India as a dumping ground for irrational fixed dose combination (FDC) drugs rejected by other count...
- Drug ban row continues as Delhi High Court extends stayJustice RS Endlaw asked the companies to provide a list of the drugs for which they were issued licenses by state licensing authorities (SL...
- NPPA backs ban on 'irrational' drugs, revises price fixation guidelinesIndia's drug pricing watchdog National Pharmaceutical Pricing Authority (NPPA) has moved in to back the health ministry.
- Delhi HC stays ban on drugs of Wockhardt, Glaxo and GriffonThe court also issued notice to the government on the companies' pleas challenging the notification and listed the petitions for hearing on...
Load More
